Psychiatry Research 1979-12-01

Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

G C Davis, A C Williams, S P Markey, M H Ebert, E D Caine, C M Reichert, I J Kopin

Index: Psychiatry Res. 1 , 249-254, (1979)

Full Text: HTML

Abstract

Abuse of 4-propyloxy-4-phenyl-N-methylpiperidine, a meperidine congener, produced parkinsonism in a 23-year-old man. Unlike other drug-induced motor disturbances, the syndrome persisted for 18 months and responded to drugs that stimulate dopamine receptors. Biogenic amines and metabolites in the cerebrospinal fluid and microscopic evaluation of the brain at necropsy were consistent with damage to aminergic neurons in the substantia nigra.


Related Compounds

Related Articles:

Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.

2013-01-01

[PLoS ONE 8(5) , e63527, (2013)]

Gas-liquid chromatographic-mass spectrometric determination of 1-methyl-4-phenyl-4-propionoxypiperidine using a stable isotope-labeled analogue as an internal standard.

[J. Chromatogr. A. 408 , 356-9, (1987)]

Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.

2005-06-01

[Glycobiology 15(6) , 585-91, (2005)]

Apoptosis-induced inhibition of CD1d-mediated antigen presentation: different roles for caspases and signal transduction pathways.

2008-09-01

[Immunology 125(1) , 80-90, (2008)]

Modulation of amyloid precursor protein processing by synthetic ceramide analogues.

2010-08-01

[Biochim. Biophys. Acta 1801(8) , 887-95, (2010)]

More Articles...